the aid library

LIST OPTIONS

Filter

5530

Sort by:

Direction:

Download (45)

View PDF (1002)

Factsheet for experts - Antimicrobial resistance

European Centers for Disease Control and Prevention ECDC (2019) CC

Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th... more

Download (83)

View PDF (125)

Sierra Leone: National Strategy Plan for Combating Antimicrobial Resistance

Ministry of Health and Sanitation Sierra Leone (2018) C_WHO

Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ... more

Download (955)

View PDF (2330)

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action
recommended

ADCAP Age & Disability Capacity; USAID; UKAid; IFRC; et al. Help Age International (2015) CC

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action inform the design, implementation, monitoring and evaluation of humanitarian programmes across all sectors and phases of response, and in all emergency contexts, ensuring older people and people with disabilities are not e... more

Download (184)

View PDF (213)

Rwanda Service Provision Assessment Survey 2007

National Institute of Statistics (NIS) [Rwanda], Ministry of Health (MOH) [Rwanda], and Macro International Inc. (2008) C2

The 2007 Rwanda Service Provision Assessment (RSPA) was a national representative survey conducted in 538 health facilities throughout Rwanda. The survey covered hospitals, health centers, dispensaries and health posts, including all public facilities such as government and government-assisted heal... more

Download (72)

View PDF (114)

Third round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic
recommended

World Health Organization WHO (2022) C_WHO

Countries reported disruptions in all health-care settings. In more than half of countries surveyed, many people are still unable to access care at the primary care and community care levels. Significant disruptions have also been reported in emergency care, particularly concerning given the impact... more

Download (157)

View PDF (172)

A framework for mental health and psychosocial support in radiological and nuclear emergencies

World Health Organization (WHO) and InterAgency Standing Committee (IASC) (2020) C_WHO

The health impact of radiological and nuclear emergencies can last for decades. Lessons learned from past radiological and nuclear accidents have demonstrated that the mental health and psychosocial consequences can outweigh the direct physical health impacts of radiation exposure. International rad... more

Download (802)

View PDF (2015)

Recovery toolkit: Supporting countries to achieve health service resilience

World Health Organization WHO (2016) C_WHO

A key purpose of the Recovery Toolkit is to support countries in the reactivation of health services which may have suffered as a result of the emergency. These services include ongoing programmes such as immunization and vaccinations, maternal and child health services, and noncommunicable diseases... more

Download (80)

View PDF (105)

Guidelines for Maternity Care in South Africa - fourth edition 2016

Maternal Health Committee of the National Department of Health (NDoH) South Africa NDoH South Africa (2016) CC

These guidelines have been prepared by the Sub directorate: Maternal Health for the guidance of health workers (doctors and midwives) providing obstetric, surgical and anaesthetic services for pregnant women in district clinics, health centres and district hospitals. These guidelines are intended fo... more

Download (83)

View PDF (116)

Falls in older people

National Institute for Health Care and Excellence NICE (2015) C2

This quality standard covers prevention of falls and assessment after a fall in older people (aged 65 and over) who are living in the community or staying in hospital. It describes high-quality care in priority areas for improvement.

Download (2047)

View PDF (2034)

Environmental Health Management After Natural Disaster
recommended

Ruth Newman, Richard Hansen, John Quigley and Don Schramm Pan American Health Organization (2003) C_WHO

Natural disasters often increase morbidity and mortality rates. Taking appropriate measures to maintain environmental health helps to reduce or eliminate the risks of preventable disease and death. Such measures contribute not only to the health of individuals in and near disaster-stricken areas, bu... more

Download (356)

View PDF (737)

Antimicrobial Stewardship Program Guideline (India)
recommended

Balaji, V., P. Rupali, K. Walia, et al. Indian Council of Medical Research (2018) C2

Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o... more

Download (186)

View PDF (214)

A Matter of Life and Death: Tackling Violence against Health Care in Pakistan, Peru and El Salvador

International Committee of the Red Cross (ICRC) (2017) C1

Every day, health-care providers are being attacked, patients discriminated against, ambulances held up at checkpoints, hospitals bombed, medical supplies looted and entire communities cut off from critical services around the world.
Between January 2012 and December 2014, the ICRC documented n... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action recommended

Third round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic recommended

Environmental Health Management After Natural Disaster recommended

Antimicrobial Stewardship Program Guideline (India) recommended

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action
recommended

Third round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic
recommended

Environmental Health Management After Natural Disaster
recommended

Antimicrobial Stewardship Program Guideline (India)
recommended